The association between interleukin-6 polymorphisms and rheumatoid arthritis: A meta-analysis

Inflammation Research

Volumn 61, Issue 7, 2012, Pages 665-671

  Lee, Young Ho ^a   Bae, Sang Cheol ^b   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a Korea University College of Medicine   (South Korea)

^b Hanyang University Medical Center   (South Korea)

Author keywords

Interleukin 6; Meta analysis; Polymorphism; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 6;

ALLELE; ARTICLE; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPEAN; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; IL6 GENE; POPULATION RESEARCH; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TREND STUDY;

ARTHRITIS, RHEUMATOID; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, GENETIC;

EID: 84865145810     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0459-1     Document Type: Article

References (35)

1. Choi SJ, Rho YH, Ji JD, Song GG, Lee YH. Genome scan metaanalysis of rheumatoid arthritis. Rheumatology (Oxford). 2006; 45:166-70. (Pubitemid 43160077)
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678.
3. Fonseca JE, Santos MJ, Canhao H, Choy E. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev. 2009;8:538-42.
4. Nurnberg W, Haas N, Schadendorf D, Czarnetzki BM. Interleukin- 6 expression in the skin of patients with lupus erythematosus. Exp Dermatol. 1995;4:52-7.
5. Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo- controlled trial. Ann Rheum Dis. 2008;67:1516-23.
6. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369-76. (Pubitemid 28467565)
7. Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H. Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int. 2011 (Epub ahead of print) http://dx.doi.org/10.1007/s00296-011- 2057-x.
8. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J, Martin J, Gonzalez-Gay MA. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2009;27: 964-70.
9. Trajkov D, Mishevska-Perchinkova S, Karadzova-Stojanoska A, Petlichkovski A, Strezova A, Spiroski M. Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol. 2009;28:1291-300.
10. Panoulas VF, Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Milionis HJ, Douglas KM, Nightingale P, Kitas GD. Association of interleukin-6 (IL-6) -174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis. 2009;204:178-83.
11. Huang XZ, Zhuang JH, Ren YG, Zhou LJ, Zhou Q. Association of interleukin-6 and interleukin-18 gene polymorphism with rheumatoid arthritis in Guangdong Han population. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27:1661-4.
12. Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M. IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol. 2005;34:109-13. (Pubitemid 40694829)
13. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 2003;4:117-21. (Pubitemid 38967585)
14. Crilly A, Bartlett JM, White A, Stirling D, Capell H, Madhok R. Investigation of novel polymorphisms within the 30 region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis. Cytokine. 2001;13:109-12. (Pubitemid 32579317)
15. Fugger L, Morling N, Bendtzen K, Ryder L, Andersen V, Heilman C, Karup Pedersen F, Friis J, Halbert P, Svejgaard A. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J Immunogenet. 1989;16:461-5. (Pubitemid 20241512)
16. LeeYH, RhoYH, Choi SJ, Ji JD, SongGG,Nath SK, Harley JB. The PTPN22 C1858T functional polymorphism and autoimmune diseases- a meta-analysis. Rheumatology (Oxford). 2007;46:49-56. (Pubitemid 44932783)
17. Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet. 2006;14:364-71.
18. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Association of TNFalpha -308 G/A polymorphism with responsiveness to TNFalpha- blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2006;27:157-61. (Pubitemid 46088273)
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315: 629-34. (Pubitemid 27387172)
20. Davey Smith G, Egger M. Meta-analyses of randomised controlled trials. Lancet. 1997;350:1182.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002;21:1539-58.
23. Lopez-Mejias R, Garcia-Bermudez M, Gonzalez-Juanatey C, Castaneda S, Perez-Esteban S, Miranda-Filloy JA, Gomez- Vaquero C, Fernandez-Gutierrez B, Balsa A, Pascual-Salcedo D, Blanco R, Gonzalez-Alvaro I, Llorca J, Martin J, Gonzalez-Gay MA. Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis. 2011;219:655-8.
24. Lo SF, Huang CM, Lin HC, Chen WC, Tsai CH, Tsai FJ. Cytokine (IL-6) and chemokine (IL-8) gene polymorphisms among rheumatoid arthritis patients in Taiwan. Clin Exp Rheumatol. 2008;26:632-7.
25. Blankenstein T, Volk HD, Techert-Jendrusch C, Qin ZH, Richter G, Diamantstein T. Lack of correlation between BglII RFLP in the human interleukin 6 gene and rheumatoid arthritis. Nucleic Acids Res. 1989;17:8902. (Pubitemid 19273919)
26. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int. 2007;27:827-33. (Pubitemid 46906647)
27. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus. 2009;18:9-15.
28. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Association between the CTLA-4 ?49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep (Epub ahead of print) doi:10.1007/s11033-011-1364-3
29. Morse HR, Olomolaiye OO, Wood NA, Keen LJ, Bidwell JL. Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine. 1999;11:789-95. (Pubitemid 29460478)
30. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford). 2001;40:656-61.
31. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE. Interleukin-6 gene - 174gc and -572gc promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21:1458-63. (Pubitemid 34219808)
32. Chen RH, Chang CT, Chen WC, Tsai CH, Tsai FJ. Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients. J Clin Lab Anal. 2006;20:260-5.
33. Sie MP, Sayed-Tabatabaei FA, Oei HH, Uitterlinden AG, Pols HA, Hofman A, van Duijn CM, Witteman JC. Interleukin 6-174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol. 2006;26:212-7. (Pubitemid 43732252)
34. Jeon JY, Kim HA, Kim SH, Park HS, Suh CH. Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans. J Rheumatol. 2011;37:2251-8.
35. Biswas S, Ghoshal PK, Mandal SC, Mandal N. Relation of antito pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J Intern Med. 2010;25:44-50.